Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Diabetes|June 26, 2018
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint InhibitorsAngeliki M Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, et al.Cancer Immunology Research|February 13, 2026
Ex vivo expansion of melanoma tumor infiltrating lymphocytes leads to a dominant exhausted T cell population with lack of memory markersGianfilippo Coppola, Samuel Kerr, Pei-Chun Cha, et al.Nature Immunology|May 14, 2024
The aged tumor microenvironment limits T cell control of cancerAlex C Y Chen, Sneha Jaiswal, Daniela Martinez, et al.Nature Communications|April 12, 2019
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune systemMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.Cancer|November 27, 2019
PLEKHA5 regulates tumor growth in metastatic melanomaHongyi Zhang, Huifang Zhu, Gang Deng, et al.Cancers|April 3, 2021
Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune CellsThuy T Tran, Chetan K Rane, Christopher R Zito, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2018
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II TrialHarriet M Kluger, Veronica Chiang, Amit Mahajan, et al.Cancer Immunology Research|July 21, 2023
Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 ResistanceIrina Krykbaeva, Kate Bridges, William Damsky, et al.Journal for Immunotherapy of Cancer|July 26, 2019
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaNicholas D Klemen, Melinda Wang, Paul L Feingold, et al.Pageof 6